# Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture

> **NCT00824564** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 82 (actual)

## Conditions studied

- Femoral Fractures

## Interventions

- **DRUG:** Tranexamic Acid plus standard of care
- **PROCEDURE:** Standard of care

## Key facts

- **NCT ID:** NCT00824564
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00824564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00824564, "Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00824564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*